Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...
Sobio announced the launch of its 90-day virtual recovery program beginning February 1, 2026 providing structured support ...
Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ...
For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...
Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, ...
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Monday, January 05 based on AAII’s Stock Grades.
Acidic cranberry juice can irritate the bladder and worsen UTI symptoms. When you have an active UTI, Gabal said, it’s more about flushing out the bacteria with water and other less bladder-irritating ...
The experiences of one doctor in Louisiana reveal the tensions around trying to get people to engage in addiction treatment, ...